Miller Lab at Dartmouth

Very proud of Steven! Congratulations!!

So happy that my #F31 has been officially awarded by the #NCI! Grateful for all of the support from my sponsoring team and friends who had to hear me fuss about grant writing for years😆

The Miller lab is officially going to Italy for the @EACRnews 2023 Congress! All submitted abstracts were accepted for poster presentation. @Steven_S_Tau, @AnnekaLJohnson, @AbigailEGoen Alyssa Roberts, and Bianca Romo @MCBDartmouth @MsbDartmouth

Congrats to @AnnekaLJohnson for being awarded Dartmouth Cancer Center's 2023 Scientific poster of the year! @DartmouthCancer

@Steven_S_Tau @MCBDartmouth @GeiselMed @DartGRAD @DartmouthCancer @MsbDartmouth

Congrats to @Steven_S_Tau on publishing a review in Cancer and Metastasis Review! @MCBDartmouth @GeiselMed @DartGRAD @DartmouthCancer link.springer.com/article/10.100…

Congratulations to Steven for his commentary in CCR! pubmed.ncbi.nlm.nih.gov/36626159/

Labs that work together, publish together.

Looking forward to launching a new line of investigation into "Rational combination of endocrine and radiation therapies for ER+ breast cancer" supported by a new Prouty Pilot Grant to Todd Miller, Lesley Jarvis, and Rongxiao Zhang.

Congratulations to Steven Tau on his first manuscript from his PhD work! Thanks to the entire team for their efforts to complete this pharmacology study.

Happy birthday to Bianca Romo!

Welcome to the two newest graduate students to join the Miller lab! (Alyssa Roberts & Huijuan Yang)

Congratulations to our own Steven Tau for being selected to give a platform presentation at the 2022 Cancer Molecular Therapeutics Research Association Annual Meeting!

@PEMMatDartmouth @CancerDartmouth

Congratulations to Dr. Shee et al. on acceptance of their manuscript in PLoS ONE. Integrated pan-cancer gene expression and drug sensitivity analysis reveals SLFN11 mRNA as a solid tumor biomarker predictive of sensitivity to DNA-damaging chemotherapy. @PEMMatDartmouth

@PEMMatDartmouth @CancerDartmouth

Congratulations to Drs. Fadul and Miller on publication of findings from their clinical trial in glioblastoma! Tumor pharmacokinetics and pharmacodynamics of the CDK4/6 inhibitor ribociclib in patients with recurrent glioblastoma. link.springer.com/article/10.100… @PEMMatDartmouth

@PEMMatDartmouth @KettenbachLab @CancerDartmouth

@PEMMatDartmouth @KettenbachLab

New publication! A transcriptionally-definable subgroup of triple-negative breast and ovarian cancer samples shows sensitivity to HSP90 inhibition. by Shee, Wells, Miller, et al. in Clinical Cancer Research. clincancerres.aacrjournals.org/content/early/… @PEMMatDartmouth

Awesome day of go-karting with the Gerber and Miller labs! @PEMMatDartmouth @GerberLab

Another publication! Statistical determination of synergy based on Bliss definition of drugs independence. by Demidenko and Miller in PLoS ONE. @PEMMatDartmouth